Examination of Witnesses (Questions 120-139)
PROFESSOR MARTIN
SHIRLEY, PROFESSOR
IAN CRUTE
AND PROFESSOR
CHRIS POLLOCK
1 NOVEMBER 2006
Q120 Bob Spink: Did you divert those
people from a longer term thing to deal with this and then shove
them back?
Professor Crute: That is a very
good question. It was a combination of taking proportions of people's
time to divert them on the basis of priority plus some additional
recruitment and training of staff in order to meet those objectives.
Q121 Bob Spink: Who decides the priority?
Who says, "We are going to slow this down and we are going
to divert you on to this one because the "red tops"
are running it on their front pages this week"?
Professor Shirley: One of the
great things about the institute is that we can take a long-term
view and certainly there are opportunities as a consequence of
funding streams coming in which are new. I can give you an example
with Avian flu. The Institute of Animal Health has had a long-term
programme on avian immunology and avian immunology serves many
studies on many pathogens. It is now very timely to have that
programme embedded within the Institute of Animal Health with
the types of poultry birds that we have, so we are in a position
then to bid for new money to reinforce our programmes on avian
flu. That is one way in which we can move because we have the
underpinning capability in place. It has been there for some time.
As an institute we evaluate our science programmes on a regular
basis. We constantly look at the fit-for-purpose of our programmes.
We have the ability to close programmes down if we think they
are not going in the right direction or are not productive, but
we can also start programmes up if we so wish by using our core
strategic grant. We can make those changes.
Q122 Bob Spink: Do you step back
and look at value for money, and fundamentally reassess what you
are doing long term? Do you say, "Is there a better outcome
we could get for that resource?"
Professor Pollock: Absolutely.
All the time. There is an external assessment through BBSRC, the
institute assessment exercisewhich used to be every four
years and it is now every fivewhich I believe Professor
Goodfellow described in her evidence and you would not want me
to repeat that. That provides external validation of both quality
and relevance and that is extremely important to us. We must stress
that all of us work to a mixed economy. The majority of funding
in IGER does not come from BBSRC. It is a question of providing
the service that the customer wants, to a significant degree,
and that provides another set of external validations. Within
the institute there are regular meetings with our governing body
and the external evaluation committees that we set up to look
at the strength of programmes. I would echo Martin's point that
one of the values that you get out of the institute system is
a level of resilience to cope with new procedures that come up.
We have had a long-standing programme in genetics that goes back
to Stapleton in 1919. It is currently being manifested through
work funded by Defra to look at gene flow between adjacent crops
which forms part of the regulatory framework for potential introduction
to GM. It is a combination of capability and opportunity and the
job of the director and senior management of the institute is
to keep that balance optimum.
Q123 Bob Spink: On your data sets
you mentioned Rothamsted have a 160-year archive of data sets.
Do you jealousy guard this or make it available to the research
community? Is that in this country or worldwide? Do you see that
as part of your mission?
Professor Crute: The first thing
to say is, yes, it is publicly available. People can both access
samples, which they often do, and they can also access data. Obviously
with a data set you have to use it in an informed way, so we try
to maintain contact with anybody who is using it. We have an electronic
archive which people can access and if anybody wants anything
extra they just have to talk to us.
Q124 Bob Spink: I see your colleagues
nodding, so we will leave it there. Finally, RCIs versus universities.
Do you think that research programmes in RCIs are more tightly
financially controlled than they would be in the university environment?
Professor Pollock: They are more
responsive to the external modalities of where the money comes
from and what the customer wants. They are also more tightly integrated
within the institute management because they are driven by the
sense of mission.
Professor Shirley: I would agree.
Professor Crute: I think so.
Q125 Chairman: The accusation, then,
which universities often make, that you are feather-bedded in
terms of your research programmes, is not true.
Professor Crute: I have not heard
the accusation quite put like that.
Q126 Chairman: I do not expect you
to agree with it.
Professor Crute: Probably the
way to look at this is the fact that we all have slightly different
proportions of core funding. Rothamsted is about 50:50. We get
a grant from BBSRC, which essentially is an underpinning grant
which allows us to have the continuity that we have been talking
about, and we get 50% of our funding in an open, competitive market
exactly like the universities do. To some extent, the analogy
with the universities is that our core grant from BBSRC is analogous
to the HEFCE grant that would come into universities, you might
say, to pay for academic salaries and such like. It is the same
thing.
Chairman: So we can put that one to bed.
Q127 Bob Spink: Universities have
different objectives from you as well.
Professor Pollock: Exactly.
Q128 Bob Spink: They are teaching
institutions. Do you think research conducted in RCIs is more
cost-effective than research conducted in universities?
Professor Shirley: I think that
is becoming clearer with the impact of FEC. We will have clear
views on that in due course. It is probably too early to tell.
I think the institutes are very much driven to deliver cost-effective
science. To pick up on a point that was made by Ian, the IAH has
a core grant which accounts for £10 million of our current
income and we raise £20 million from outside sources, whether
that be Defra, other research councils, industry, whatever, so
that is not featherbedding an institute; that is going out and
hard graft. The quality of the science that we do and of the people
we employ winning grants is a major factor. We stack up, as you
probably know, extraordinarily well in the hierarchy of grant-winning
income in the UK to BBSRC.
Chairman: I wanted to give you the opportunity
to counter the accusation.
Q129 Dr Harris: The universities
say that for 100% of their research work they have to compete
for these grants, sometimes big grants, and that therefore the
featherbeddingand it is an expression I have heard usedrefers
to the fact that you get 20-50% infrastructure costs from your
parent institute, whereas the vast majority of all their research
has to be funded from grants, which can come and go if they do
not win them, and the RAE, which is continual assessment effectively.
Professor Crute: Again, you have
to make sure you are comparing like with like. If you are talking
about the university situation, all the academic salaries are
essentially paid for. We have to compete essentially for our salaries.
Our core grant is analogous, as I say, to the HEFCE funding which
would be paying for academic salaries. A huge amount of the infrastructure
of universities is paid for through, essentially, income through
teaching and other such things, so, if you compare like with like,
I think we are now, as a consequence of the FEC arrangement, competing
on an absolutely level playing field.
Q130 Mr Newmark: How do you respond
to the comments by some academics that training in RCIs is isolated
and substandard to that given within universities?
Professor Pollock: With amusement.
We cannot do training unless we are linked to universities.
Q131 Mr Newmark: What value-added
are you providing in RCIs?
Professor Pollock: We provide
training and facilities that really cannot be done within universities.
There is no university that can train plant breeders because they
do not have either the long-term availability of experimental
material and plots or, in many cases, the quantitative genetics.
If you want plant breedingand the Stern report yesterday
made it abundantly clear that plant breeding is a major skill
gapthen it has to be delivered through training at Research
Council institutesin collaboration with universities. They
are all registered in universities.
Professor Crute: At Rothamsted,
we have at any one time 50 PhD students. A significant proportion
of those come from overseas, because they recognise that this
would be the place where they would get the sort of training they
are looking for.
Q132 Mr Newmark: You are saying that
in certain situations they are centres of excellence.
Professor Crute: Absolutely.
Q133 Mr Newmark: They cannot be replicated
within a more generic university environment.
Professor Crute: Absolutely. On
the quality assurance side of things, these students are all registered
through universities and are not only quality assured through
the universities but also through BBSRC's assessment. Certainly
as far as my own institute is concerned, the BBSRC assessment,
through the institute assessment exercise, rated Rothamsted at
the highest possible marks in all the four criteria that were
assessed. Wherever the criticism has come from, as Chris says,
it has to be treated with some derision.
Professor Shirley: I would endorse
the comments made by both colleagues. We have 40 PhD students.
We invest a lot of time in these students through training and
we offer them access to facilities and opportunities to study
diseases that are not available elsewhere and they are attracted
to the IAH for that reason.
Q134 Mr Newmark: What help have you
received from the BBSRC in terms of management training?
Professor Shirley: As a new appointee
to the instituteas director from July and as acting director
from November 2004I was offered and I took advantage of
mentoring with an ex-director of a BBSRC institute. Since then
BBSRC have introduced management training. The scheme is now beginning
to kick off. IAH have been involved in thatboth myself
and senior colleagues. I have also been offered opportunities
to have outside management consultancy input.
Q135 Mr Newmark: Was it particularly
helpful or not?
Professor Shirley: It was.
Q136 Mr Newmark: I know you went
on it but was it helpful to you?
Professor Shirley: Yes. I think
mentoring is particularly helpful because it addresses needs in
a fit-for-purpose way. It is a considerable opportunity to work
with somebody who knows the issues you are facing, so there is
less abstract about a mentoring scheme than there is if you perhaps
go on a more generic training course.
Professor Crute: I have been on
two-week courses at Brunel for management researcha good
many years ago now but it was essentially through previous employment
in AFRC rather than BBSRCand BBSRC are continually up-skilling
its senior management team through, for example, recently, diversity
training and things like interview training, so there are some
modules of training which are brought to our attention on a regular
basis.
Professor Pollock: I have very
little to add. Training is an obligatory subject for discussion
in our annual appraisal all the way through the institute system,
from the lowest grade right through to directors.
Q137 Mr Newmark: It may be obligatory,
but is it important?
Professor Pollock: Of course it
is important. Research management is now infinitely more complex
than it was. I have been a director for 13 years, so I have seen
a huge number of changes. It is more important now than it has
ever been.
Q138 Mr Newmark: Do you think the
Research Councils should be doing more to support training?
Professor Pollock: I think the
investment BBSRC is putting into training development schemes
via a third-party provider is both timely and proportionate.
Q139 Dr Harris: One of the purposes
of Research Council institutes is to develop scientific careers
and career opportunities. How do you see yourselves doing that
at the moment? That is an approach that cannot be taken at universities.
What do you add to the scientific career path, in general? Obviously
at the moment it is redundancy, but
Professor Pollock: Over the sort
of time we have been involved, it comes down to two lines. First,
it comes down on to health of disciplines. There are areas of
science that you have already heard about for which the Research
Council institutes provide career development opportunities for
scientists. Certainly in the whole area of understanding the ecological
consequences of novel crops and novel cropping systems, which
is going to be extremely important in Europe over the next 20
years, most of the scientific driving forces for that have come
out of institute-based research both in England and Wales and
North of the Border. So there is a health of disciplines argument
and there is also an argument that says there are opportunities
that you get within institutes to develop programmes over sustained
periods of time and acquire skills and skill mixes that are unique,
which is particularly appropriate for the study of whole system
processes in agriculture and land use. I would argue that we deliver
opportunities that are distinctive from and complementary with
those offered by HEIs.
Professor Crute: May I take a
slightly different direction in response to your question. I personallyand
I think it is true for the three institutes that you can see represented
herethat we have taken a view with regard to short-term
employment when the employment regulations changed. Effectively,
when I came to the institute between 60% and 70% of the scientific
staff were on short-term contracts. Now, something like 95% of
our staff are employed on indefinite contracts. It does not mean
to say that when funding terminates those people will not leave
the institute, but, essentially, we are giving very clear signals
to our people now, which is certainly a major change, that, provided
the funding environment is secure, we have a training environment
and, you might say, a long-term perspective that gives people
the opportunity to develop worthwhile and far-reaching scientific
careers.
|